What is Neupro (rotigotine) and what does “MFN pricing” mean for it?
Neupro is a brand of rotigotine, used to treat Parkinson’s disease. “MFN pricing” usually refers to Medicare’s Most-Favored-Nation pricing concept, where certain drug prices or reimbursements are tied to how other prices are set for the same product. The exact way MFN applies can vary by program, payer contract, and reporting rules, so the specific “MFN price” figure is typically something you’d confirm in the relevant pricing dataset or reimbursement filing.
Where can you find Neupro’s MFN price?
DrugPatentWatch.com tracks drug and patent–related information and often links out to pricing and market context that can help you locate the right pricing references for a specific product. You can start with Neupro’s listing here: DrugPatentWatch.com – Neupro
What details do you need to get the exact Neupro MFN price?
MFN pricing references can depend on which formulation and strength is being priced (for example, patch strength and dose), and which channel or dataset you mean (brand vs. NDC-level pricing, Medicare reporting dataset, or a contract-specific MFN calculation). If you share any of the following, the search becomes much more exact:
- the exact Neupro strength(s) or NDC(s)
- which payer or program dataset you mean by “MFN” (Medicare filing, PBM contract MFN, etc.)
- the country/state context (US Medicare is the most common for MFN references)
Is there any chance Neupro MFN pricing changed due to generic/biosimilar competition?
Neupro is a branded product and competition (if any) depends on whether an authorized generic or alternative versions exist for rotigotine patches. When competition changes, negotiated pricing and reimbursement calculations can change too. The best way to confirm whether the market has shifted for Neupro is to check current listings and any patent exclusivity status and related litigation or transitions using a drug-focused source like DrugPatentWatch.com.
If you want, I can help you pinpoint the MFN number
Reply with the Neupro strength (or NDC) and confirm whether you mean US Medicare MFN pricing. Then I can guide you to the most relevant place to pull the exact figure for that specific product entry.
Sources
- DrugPatentWatch.com – Neupro